HARBOURVEST PARTNERS LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 116 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HARBOURVEST PARTNERS LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$343,000
-14.9%
79,1930.0%0.04%
+15.8%
Q3 2021$403,000
-19.6%
79,1930.0%0.04%
-20.8%
Q2 2021$501,000
-18.1%
79,1930.0%0.05%
-41.5%
Q1 2021$612,000
+17.9%
79,1930.0%0.08%
-59.6%
Q4 2020$519,000
-1.5%
79,1930.0%0.20%
+4.1%
Q3 2020$527,000
-20.2%
79,1930.0%0.20%
-31.3%
Q2 2020$660,000
+8.7%
79,1930.0%0.28%
-3.1%
Q1 2020$607,000
-7.8%
79,1930.0%0.29%
+8.1%
Q4 2019$658,000
+12.7%
79,1930.0%0.27%
+11.5%
Q3 2019$584,000
-67.2%
79,193
-50.0%
0.24%
-27.0%
Q2 2019$1,778,000
+108.9%
158,386
+100.0%
0.33%
+10.6%
Q1 2019$851,000
-28.8%
79,1930.0%0.30%
-46.9%
Q4 2018$1,196,000
-16.4%
79,1930.0%0.57%
-56.1%
Q3 2018$1,430,000
-21.0%
79,1930.0%1.29%
-43.4%
Q2 2018$1,810,000
+197.7%
79,193
+102.0%
2.29%
+772.5%
Q2 2017$608,000
+40.7%
39,199
+56.8%
0.26%
+8.3%
Q1 2017$432,000
+96.4%
25,000
+25.0%
0.24%
+261.2%
Q4 2016$220,000
+115.7%
20,000
+100.0%
0.07%
+36.7%
Q2 2016$102,00010,0000.05%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
BVF INC/IL 5,803,700$25,130,0000.91%
Altium Capital Management LP 663,800$2,874,0000.79%
Rubric Capital Management LP 2,406,449$10,420,0000.49%
RTW INVESTMENTS, LP 6,029,700$26,109,0000.38%
Orbimed Advisors 3,214,509$13,919,0000.18%
TANG CAPITAL MANAGEMENT LLC 152,345$660,0000.13%
PLATINUM INVESTMENT MANAGEMENT LTD 980,085$4,244,0000.12%
Point72 Asset Management, L.P. 6,303,025$27,292,0000.11%
Sender Co & Partners, Inc. 40,720$176,0000.09%
Manteio Capital LLC 15,067$65,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders